tiprankstipranks
Trending News
More News >
Metall Zug AG Class B (CH:METN)
:METN
Advertisement

Metall Zug AG (METN) AI Stock Analysis

Compare
0 Followers

Top Page

CH:METN

Metall Zug AG

(METN)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 4o)
Rating:48Neutral
Price Target:
CHF752.00
▲(1.35% Upside)
The overall stock score is primarily influenced by weak financial performance and technical analysis. The company's negative cash flow and declining revenue trends are significant concerns, compounded by bearish technical indicators. The valuation is also impacted by a negative P/E ratio, though the dividend yield offers some compensation.

Metall Zug AG (METN) vs. iShares MSCI Switzerland ETF (EWL)

Metall Zug AG Business Overview & Revenue Model

Company DescriptionMetall Zug AG, through its subsidiaries, engages in the wire processing, medical devices, infection control, technologycluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally. The company's Wire Processing business unit develops, produces, and distributes semiautomatic and fully automatic machines for cutting and stripping, crimping, sealing, twisting, tinning, printing, quality control, and process and test automation for various wires and cables. This segment also offers software packages for optimizing machine efficiency and utilization for complex applications and connection of data. Its Medical Devices business unit develops, produces, and distributes diagnosis and microsurgery products primarily in the fields of ophthalmology, as well as covers applications in the fields of pulmonology and measuring instruments. This business unit offers diagnostics products, including slit lamps, biometry, perimetry, tonometer, and practice management software for clinics and opticians, as well as practice equipment; and surgical products, such as microscopes, floor and roof stands, and accessories. The company's Infection Control business unit provides cleaning, disinfection, and sterilization solutions that are used in hospitals. Its Technologycluster & Infrastructure business unit engages in the management and development of real estate. The company's Others business unit offers cleaning, disinfection and sterilization systems and solutions primarily for use in the pharmaceutical industry; and professional appliances and integrated solutions, such as dishwasher and cooking technology, cleaning agents, and care systems for the hotel and catering industry, care homes, and hospitals. Metall Zug AG was founded in 1887 and is headquartered in Zug, Switzerland.
How the Company Makes MoneyMetall Zug AG generates revenue through multiple key streams, primarily from its operations in medical technology and precision engineering. The company earns money by manufacturing and selling medical devices, which are used in hospitals and healthcare facilities worldwide. Additionally, it produces precision components for various industries, contributing to its revenue through direct sales and long-term contracts with clients. The company has established significant partnerships with healthcare organizations and industrial players, enhancing its market reach and stability. Furthermore, Metall Zug AG benefits from ongoing investments in research and development, enabling it to introduce innovative products that cater to evolving market demands, thus driving sales growth and profitability.

Metall Zug AG Financial Statement Overview

Summary
Metall Zug AG faces challenges in maintaining revenue growth and profitability while demonstrating strong balance sheet stability with low leverage. However, negative cash flow trends pose risks to financial flexibility, necessitating improvements in cash-generating activities to support future operations.
Income Statement
55
Neutral
The company has shown volatile revenue trends with a significant decline in recent years. Gross profit margin has been relatively stable but with a decreasing trend in total revenue. The net profit margin improved from previous losses, indicating better cost management, but overall profitability remains a challenge.
Balance Sheet
70
Positive
The company maintains a strong equity ratio and low debt levels, which enhances financial stability. However, the decrease in stockholders' equity and total assets over the years poses concerns about long-term asset management and growth potential.
Cash Flow
45
Neutral
Free cash flow has been negative in recent years, indicating insufficient cash generation to support capital expenditures and other financial obligations. The operating cash flow has also declined, highlighting potential liquidity issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue196.47M283.42M494.71M645.94M661.89M823.54M
Gross Profit64.00M90.95M151.65M226.69M228.21M261.41M
EBITDA-2.67M68.07M43.12M151.73M59.55M43.00M
Net Income-12.77M52.59M22.22M129.98M48.78M14.31M
Balance Sheet
Total Assets647.08M632.95M690.66M701.19M715.63M635.24M
Cash, Cash Equivalents and Short-Term Investments14.61M17.25M29.80M31.73M81.84M72.27M
Total Debt124.67M82.81M36.60M17.00M4.17M4.65M
Total Liabilities188.78M146.54M168.84M182.89M199.44M152.34M
Stockholders Equity392.37M419.24M455.51M453.36M450.94M418.25M
Cash Flow
Free Cash Flow-43.50M-31.13M-25.96M-40.72M14.27M14.20M
Operating Cash Flow-8.31M2.77M9.52M-5.93M48.98M60.26M
Investing Cash Flow-65.27M-53.54M-16.41M-41.81M-32.35M-63.23M
Financing Cash Flow69.59M37.44M6.89M-632.00K-8.21M-76.13M

Metall Zug AG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price742.00
Price Trends
50DMA
821.12
Negative
100DMA
915.41
Negative
200DMA
978.90
Negative
Market Momentum
MACD
-24.74
Negative
RSI
37.84
Neutral
STOCH
16.19
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:METN, the sentiment is Negative. The current price of 742 is below the 20-day moving average (MA) of 765.70, below the 50-day MA of 821.12, and below the 200-day MA of 978.90, indicating a bearish trend. The MACD of -24.74 indicates Negative momentum. The RSI at 37.84 is Neutral, neither overbought nor oversold. The STOCH value of 16.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:METN.

Metall Zug AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
CHF325.20M10.4914.20%2.52%-1.94%6.63%
72
Outperform
CHF287.90M34.110.16%-0.64%-5.79%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
58
Neutral
$367.97M62.370.83%5.78%-5.85%-83.70%
50
Neutral
CHF336.97M-3.2887.74%
48
Neutral
$334.41M-26.29-3.04%2.70%-56.09%-118.83%
45
Neutral
$139.98M-3.01-9.74%-15.70%-670.93%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CH:METN
Metall Zug AG
742.00
-406.23
-35.38%
CH:FTON
Feintool International Holding AG
9.60
-6.60
-40.74%
CH:MIKN
Mikron Holding AG
19.86
5.79
41.10%
CH:SWTQ
Schweiter Technologies AG
259.50
-144.71
-35.80%
CH:ARBN
Arbonia AG
4.94
-1.08
-18.00%
CH:ELMN
Elma Electronic AG
1,260.00
221.89
21.37%

Metall Zug AG Corporate Events

Metall Zug AG Faces Challenges but Remains Optimistic with New Innovations
Aug 25, 2025

Metall Zug AG reported a challenging first half of 2025, with net sales significantly declining to CHF 94.2 million, primarily due to the divestment of Belimed and negative currency effects. Despite these challenges, the company is optimistic about future growth, driven by new product launches from its Haag-Streit unit, including the world-first Elara 900 slit lamp. The ongoing integration of SteelcoBelimed is on track, with initial synergies expected to improve operational efficiency. The company is also undergoing a leadership change at Haag-Streit, with Thomas Lenzen taking over as CEO to continue driving international growth and innovation.

The most recent analyst rating on (CH:METN) stock is a Hold with a CHF1082.00 price target. To see the full list of analyst forecasts on Metall Zug AG stock, see the CH:METN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025